Multi-Modal CRISPR Platform for Simultaneous Editing and Monitoring

The convergence of genome editing and biosensor technologies has created an unprecedented opportunity to develop therapeutic platforms that not only correct disease-causing mutations but also provide real-time feedback on treatment efficacy. Multi-modal CRISPR systems represent a fundamental departure from conventional gene therapy approaches by integrating therapeutic editing with continuous monitoring capabilities in a single intervention. This concept emerges from the recognition that neurode...